COVID-19. Coronavirus infection, unspecified
Conditions
Interventions
Intervention 1: Intervention group: People in the intervention group will receive nanocurcumin supplement at a dose of 160 mg per day for 6 days. Curcumin is a natural polyphenolic antioxidant respon
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: Confirmation of Covid-19 by positive PCR test or lung scan Admission to hospital Corona wards other than ICU Filling out the informed consent form by the patient or the patient's first-degree relatives
Exclusion criteria
Exclusion criteria: Chemotherapy People living with HIV History of heart attack and stroke in the last 3 months History of CABG Dialysis patients Transplantation of body organs Pregnancy and lactation People with BMI above 40 Known food allergies Having any liver failure Malignancies Uncontrolled Diabetes (A1c>7.5)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hs-CRP. Timepoint: Before and after 6 days of supplementation. Method of measurement: ELISA.;Percentage of recovery. Timepoint: Before and after 6 days of supplementation. Method of measurement: CT scan of the lungs. | — |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of oxygen saturation. Timepoint: Before the intervention and then daily until discharge. Method of measurement: Pulse oximeter.;Severity of infection symptoms of upper and lower respiratory tract. Timepoint: Before the intervention and then daily during the supplementation period. Method of measurement: Questionnaire.;Complete Blood Count. Timepoint: Before and after 6 days of supplementation. Method of measurement: Automated cell count. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Javad Hossein Zadeh
Tehran University of Medical Sciences
Outcome results
None listed